2013
Contraceptive Failures in Overweight and Obese Combined Hormonal Contraceptive Users
McNicholas C, Zhao Q, Secura G, Allsworth J, Madden T, Peipert J. Contraceptive Failures in Overweight and Obese Combined Hormonal Contraceptive Users. Obstetrical & Gynecological Survey 2013, 68: 736-737. DOI: 10.1097/01.ogx.0000435765.37327.d9.Peer-Reviewed Original ResearchBody mass indexSignificant risk factorsContraceptive failureUnintended pregnancyVaginal ringMass indexObese femalesRisk factorsPrevious unintended pregnancyProspective cohort studyIdeal body weightHormonal contraceptive usersContraceptive vaginal ringContraceptive failure ratesReproductive age femalesReversible contraceptive methodsFailure rateContraceptive CHOICE ProjectSt Louis areaCohort studyObese womenBMI categoriesClinical outcomesHormonal contraceptionContraceptive usersContraceptive Failures in Overweight and Obese Combined Hormonal Contraceptive Users
McNicholas C, Zhao Q, Secura G, Allsworth J, Madden T, Peipert J. Contraceptive Failures in Overweight and Obese Combined Hormonal Contraceptive Users. Obstetrics And Gynecology 2013, 121: 585-592. PMID: 23635622, PMCID: PMC4009704, DOI: 10.1097/aog.0b013e31828317cc.Peer-Reviewed Original ResearchConceptsOral contraceptive pillsBody mass indexUnintended pregnancyContraceptive failureVaginal ringPrevious unintended pregnancyHormonal contraceptive usersSignificant risk factorsVaginal ring usersContraceptive vaginal ringContraceptive failure ratesFailure rateContraceptive studyBMI categoriesMass indexContraceptive pillsObese femalesContraceptive usersRisk factorsRing usersTransdermal patchPregnancyReversible methodFailureFemales
2012
The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters
Aagaard K, Petrosino J, Keitel W, Watson M, Katancik J, Garcia N, Patel S, Cutting M, Madden T, Hamilton H, Harris E, Gevers D, Simone G, McInnes P, Versalovic J. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. The FASEB Journal 2012, 27: 1012-1022. PMID: 23165986, PMCID: PMC3574278, DOI: 10.1096/fj.12-220806.Peer-Reviewed Original ResearchConceptsBody mass indexGood Clinical Practice standardsSubsequent physical examinationClinical practice standardsOral healthMass indexCutaneous lesionsSystemic diseasePhysical examinationReference cohortGastrointestinal tractExclusion criteriaOral cavityHealth historyPotential immunomodulatorClinical designBody sitesLongitudinal changesPrimary specimensPotential participantsHuman Microbiome ProjectPractice standardsIndividual microbiomesHuman microbiomeRecent useContraceptive Failure Rates of Etonogestrel Subdermal Implants in Overweight and Obese Women
Xu H, Wade J, Peipert J, Zhao Q, Madden T, Secura G. Contraceptive Failure Rates of Etonogestrel Subdermal Implants in Overweight and Obese Women. Obstetrics And Gynecology 2012, 120: 21-26. PMID: 22678035, PMCID: PMC4043143, DOI: 10.1097/aog.0b013e318259565a.Peer-Reviewed Original ResearchConceptsObese womenContraceptive failure ratesIntrauterine deviceContraceptive methodsFirst-line contraceptive methodLarge prospective cohort studyKaplan-Meier survival curvesActing reversible contraceptive (LARC) methodsUrine pregnancy testingProspective cohort studyBody mass indexEtonogestrel subdermal contraceptive implantEtonogestrel subdermal implantSubdermal contraceptive implantFailure rateReversible contraceptive methodsT-testContraceptive CHOICE ProjectStudent's t-testReliable birth control methodsBirth control methodsCohort studyCumulative failure rateNormal weightMass index